Optiscan Imaging (ASX:OIL) Notes Receivable : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Optiscan Imaging Notes Receivable?

Optiscan Imaging's Notes Receivable for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Optiscan Imaging Notes Receivable Historical Data

The historical data trend for Optiscan Imaging's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optiscan Imaging Notes Receivable Chart

Optiscan Imaging Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Notes Receivable

Get a 7-Day Free Trial

Optiscan Imaging Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Optiscan Imaging Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Optiscan Imaging Notes Receivable Related Terms

Thank you for viewing the detailed overview of Optiscan Imaging's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Optiscan Imaging Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Optiscan Imaging Ltd (ASX:OIL) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Miles Street, Mulgrave, Melbourne, VIC, AUS, 3170

Website

https://www.optiscan.com

Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.